<DOC>
	<DOCNO>NCT03000855</DOCNO>
	<brief_summary>EUS - guide choledocho-duodenostomy ( ECDS ) establish option bile duct drainage unresectable malignant distal CBD strictures endoscopic retrograde cholangiopancreatography ( ERCP ) fail . However , primary ECDS compare ERCP cover self-expanding metallic stent ( CSEMS ) unresectable malignant distal CBD strictures uncertain . The aim current study compare primary ECDS versus ERCP CSEMS unresectable malignant distal CBD strictures . We hypothesis ECDS associate high 1-year stent patency rate .</brief_summary>
	<brief_title>EUS - Guided Choledocho-duodenostomy Versus ERCP With Covered Metallic Stents Patients With Unresectable Malignant Distal Common Bile Duct Strictures</brief_title>
	<detailed_description>Malignant biliary obstruction common sequela pancreatic cancer distal bile duct cancer , development hinder use chemotherapy , decrease patient quality life decrease survival . Malignant biliary obstruction traditionally palliate ERCP metallic stent insertion . However , stent prone obstruction due tumour ingrowth . In addition , ERCP may always possible due tumour obstruction percutaneous biliary drainage may require . Recently , ECDS describe alternative percutaneous biliary drainage patient fail ERCP . The procedure also associate potential advantage compare conventional ERCP . In particular , risk tumour ingrowth stent place ECDS low stent patency rate may better ERCP . Thus , aim current study compare primary ECDS versus ERCP CSEMS unresectable malignant distal CBD strictures .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<criteria>Age ≥ 18 year old informed consent Histologically ( prefer ) radiologically confirm distal malignant bile duct tumor Inoperability staging , comorbidities patient wish Distal tumor 2cm away portal hilum Bilirubin &gt; 50umol/L diagnosis Multiple hepatic metastasis significant blockage one liver segment ( segment blockage , metastasis exclusion criterion ) Presence main portal vein thrombosis Prior SEMS placement Intraductal papillary mucinous carcinoma Prior Billroth II rouxen Y reconstruction History bleed disorder use anticoagulation Child 's B/C cirrhosis Pregnancy Performance status ECOG ≥3 ( confine bed / chair &gt; 50 % waking hour ) Presence malignancy Life expectancy &lt; 3months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Malignant biliary obstruction</keyword>
	<keyword>EUS - guide choledocho-duodenostomy</keyword>
	<keyword>ERCP cover metallic stent</keyword>
</DOC>